GEODE CAPITAL MANAGEMENT, LLC - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 93 filers reported holding EIDOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$24,106,000
+176.4%
183,207
+6.2%
0.00%
+100.0%
Q3 2020$8,720,000
+25.9%
172,574
+18.7%
0.00%
+100.0%
Q2 2020$6,928,000
-0.1%
145,348
+2.7%
0.00%
-50.0%
Q1 2020$6,934,000
-50.6%
141,543
-42.1%
0.00%
+100.0%
Q4 2019$14,038,000
+225.1%
244,610
+103.7%
0.00%0.0%
Q3 2019$4,318,000
+12.3%
120,068
-3.0%
0.00%0.0%
Q2 2019$3,846,000
+30.9%
123,775
-1.2%
0.00%0.0%
Q1 2019$2,937,000
+33.4%
125,263
-21.7%
0.00%
Q4 2018$2,202,000
+605.8%
160,042
+410.3%
0.00%
Q3 2018$312,00031,3620.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders